Technologies Employed at IHH

monalisa touch

Information on technologies employed at IHH.

CO2 Fractional Laser Therapy – MonaLisa Touch®

MonaLisa Touch® is an innovative laser procedure, designed and produced by DEKA (Italy), that delivers fractional CO2 laser energy to the vaginal wall tissue, benefiting a woman’s overall urogenital health. The procedure is performed in an office environment without the need for anesthesia and with virtually no pain or side effects. It was approved by Health Canada in 2016.

Issues of urogenital health are commonly seen in post-menopausal women, breast cancer survivors and women who have had a hysterectomy with bilateral oophorectomy. In the US, as many as 50% of 64 million post-menopausal women suffer from changes to their gynecologic health*, and over 2.8M breast cancer survivors**.
* US Census, 2010   ** National Institutes of Health 2011

The following histological images show the vaginal mucosa before and after the MonaLisa Touch® treatment. The marked change to the epithelium post-treatment is clearly illustrated.

Histological preparation of a section of the vaginal mucosa stained with haematoxylin and eosin (H&E). (A) Vaginal mucosa in the basal condition with a thinner epithelium. (B) The same patient two months after a session with the MonaLisa Touch®. The thicker epithelium and shedding of numerous big cells from the free surface, together with the larger diameter of epithelial cells rich in glycogen, demonstrate the restored metabolic trophism and dynamics of the whole epithelium. [Courtesy of Prof. A. Calligaro. University of Pavia, Italy]

Monalisa Touch

Two Renewal Mechanisms in One.
• Ablation
• Thermal Effect

SYMPTOMS IMPROVEMENT (%) AFTER 3 MONALISA TOUCH® TREATMENTS IN MENOPAUSE PATIENTS

BURNING ITCHING DRYNESS DYSPAREUNIA LAXITY
84% 85% 76% 72% 90%
*Courtesy of Prof. S.Salvatore – Hospital San Raffaele, Milan (Italy)

Bladder urgency, frequency and mild stress incontinence can also be significantly improved in menopausal patients.

Urogenital atrophy is a very common condition, especially among women in menopause (either natural or surgical) or during postpartum. The vulvovaginal region is very sensitive to estrogen decline, with a series of consequences that impact directly on the quality of a woman’s life: weakness and laxity of the vaginal mucosa, dryness, itching and burning, and pain during sexual intercourse (dyspareunia). Other related symptoms include burning with urination, the need for frequent and urgent urination, stress incontinence and recurrent urinary tract infections.

MonaLisa Touch® is the only procedure proven not only by clinical results but also by detailed ultrastructural and histological studies. Scientific publications of the results demonstrate the effective tissue regeneration achieved thanks to the unique combination of the wavelength of the CO2 laser, the structure of the D-Pulse and adequate emission power.

With MonaLisa Touch® comes a method, with a unique concept, for restoring the atrophic conditions of the urogenital region.

During menopause, the mucosa has metabolically quiescent fibrocytes as opposed to fibroblasts, unable to actively produce collagen, hyaluronic acid and other molecules needed for an adequate glycoprotein ground matrix. This can result in dry mucosa because it is dehydrated and less well-nourished, meaning it is fragile and more prone to infections. Similarly, the declining estrogen levels of menopause also creates the same picture in the tissues surrounding the bladder and urethra resulting in various forms of incontinence and recurrent bladder infections.

What clinical trials have been conducted on the MonaLisa Touch®? 

A multisite study was conducted by Dr. Mickey Karram, Director of Fellowship Program on Female Pelvic Medicine & Reconstructive Surgery at The Christ Hospital, Cincinnati, OH and Dr. Eric Sokol, Associate Professor of Obstetrics and Gynecology at the Stanford University Medical Center.

The trial assessed the use of CO2 fractional laser therapy on 30 women with gynecological health issues due to natural or induced menopause. All patients in the trial were treated with the MonaLisa Touch® laser therapy. Results were:
• Overwhelmingly positive with immediate results
• Highly statistically significant improvement in symptoms after first treatment
• Escalation of progress with each subsequent treatment

*Women in the study either experienced natural menopause or induced menopause as the result of hysterectomy or drug-induced suppression of ovarian function (chemotherapy, radiations, and anticancer drugs such as Tamoxifen).

A study was done by Dr. Stefano Salvatore, Department of Obstetrics and Gynecology, Vita-Salute San Raffaele University to assess the feasibility of C02 fractional laser in the treatment of 50 women suffering changes in their gynecologic health.

• 42 patients (84%) showed significant improvement in their physical and mental quality of life scores over baseline and were satisfied with the treatment. Gynecologic symptoms were significantly improved.


Photobiomodulation Therapy – vSculpt Pro®

Photobiomodulation, also known as low-level light therapy (LLLT), is a noninvasive, painless treatment utilizing LEDs to stimulate cellular function. vSculpt Pro®’s red light and near-infrared lights are optimized for cellular healing, increased circulation, and reduced inflammation and pain within the vaginal mucosa.

vSculpt Pro® LEDs encourage muscle, nerve, and connective tissue cells to enhance their functions. This up-regulation of cellular function can in turn help with vaginal lubrication, collagen and elastin production, nerve healing, and increased voluntary muscle control. This results in reduced bladder incontinence, increased vaginal lubrication and sensation, and overall toning and tightening of the pelvic floor muscles.

vSculpt Pro® is an affordable approach and its therapy can be completed in the privacy of a woman’s home. At IHH, we offer vSculpt Pro® both as a complement to CO2 ffractional laser therapy and as a stand-alone treatment option.

How does vSculpt Pro® therapy help with lubrication?

With menopause, declining estrogen levels produce changes in a woman’s body that lead to less blood flow and thinning of the vaginal mucosal tissue. This condition, called vaginal atrophy, affects both the vagina and the external female genitalia (vulva). Dry, fragile vaginal tissues are susceptible to injury, tearing, and bleeding. As a result, many postmenopausal women suffer from dryness, irritation, and pain during intercourse. For some women, it can develop into vaginismus, with pain so severe they avoid sex altogether. Vaginal atrophy may be associated with a shorter and narrower vagina, which can result in pain when a woman does have sex, even with the use of a lubricant.

Vaginal lubrication originates from the lamina propria, which contains elastic fibers, blood vessels, lymphatic, and nerves, as well as glands that secrete mucus and serous fluids. Menopause, childbirth, and even certain medications can interrupt the functioning of the lamina propria.

How does vSculpt Pro® utilize LEDs in its therapy? 

vSculpt Pro® utilizes therapeutic LEDs, in addition to gentle heat, and sonic vibration—an innovative combination of technologies—to restore post-pregnancy or menopausal tissue and muscle back to optimal condition.

vSculpt Pro® utilizes light in the 662nm (red) and 855nm (infrared) spectrums, two parts of the normal broad spectrum light profile. These particular wavelengths increase cellular activity and energy levels to encourage the cells of muscles, nerves, and connective tissues to up-regulate their normal functions. This up-regulation of cellular function, in turn, helps with lubrication, collagen and elastin production, nerve healing, and increased voluntary muscle control.

Research has shown that the prime receivers of light energy are mitochondria, the control centers of cellular activity. When Low-level light therapy (LLLT) stimulates the mitochondrial factory, increased oxygen and other nutrients are made available to it, allowing for muscle repair and strengthening. Voluntary muscle control is exercised by nerve function. vSculpt Pro® enhances the feedback loop in the nerves for maintaining involuntary (baseline) tone to the pelvic floor muscles and provides users better voluntary control over those muscles. The voluntary pelvic floor muscles are a figure eight that surrounds the vaginal, anal, and urethral openings. By strengthening the muscles of the pelvic floor, vSculpt Pro® can have a positive impact on bladder control.

Heat increases blood flow, which increases oxygen at the tissue and cellular levels. It also increases nutrients to the muscles and promotes the formation of new blood vessels. Additional blood vessels, oxygen, and nutrients provide the muscles more fuel. Ultimately this results in enhanced performance of the muscles. Heat, specific to vSculpt Pro®, increases the performance and strength of the pelvic floor muscles.

Has this technology been clinically tested?

Yes. The results of our 2016 study of vSculpt Pro® were published in the peer-reviewed journal, The International Urogynecology Journal. Forty-eight female participants used vSculpt Pro® every other day for 50 days. Highlights of our study’s extraordinary results include:
• 90% of participants saw a reduction in bladder leakage
• 82% improved their pelvic floor muscle strength
• 81% saw an improvement in sexual function
Read our full clinical validation report here.
In a second study, Joylux, Inc., owner of vSculpt Pro®, engaged The Benchmarking Company to enlist 24 women to test vSculpt Pro® over the course of 60 days. At select intervals throughout the study timeframe, women answered questions regarding instances of urinary incontinence, their state of sexual function, and other differences or improvements. Questions were also asked of participants’ husbands/partners, i.e. whether they noticed changes in the degree of vaginal toning during intercourse.
Female participants who used vSculpt Pro® reported the following results, among others:
• 90% had less urinary incontinence
• 95% felt improved vaginal tightness
• 91% no longer experienced uncomfortable vaginal dryness with sex


Microcurrent Point Stimulation Therapy – Dolphin Neurostim™

microcurrent-point-stimulation-hormonal-health

MPS (Microcurrent Point Stimulation) Therapy is a hybrid modality combining the principles of acupuncture and modern neurology to provide neuro-myofascial pain relief. Modern Western science and ancient Chinese medicine work hand in hand to provide highly effective, all-natural relief from chronic pain. Designed to treat chronic and acute soft tissue pain, and scars and adhesions, by applying concentrated microcurrent impulses, this therapy provides quick and effective pain relief for a long list of medical conditions.

Dolphin Neurostim™ is a hand-held microcurrent point stimulation device, similar to transcutaneous electrical nerve stimulators (TENS), specifically designed for temporary muscular pain relief. It is a hybrid modality that applies concentrated, low frequency, DC microcurrent stimulation (at 10K ohms) to a special combination of key acupuncture, motor, and trigger points for the treatment of pain and the release of scar tissue and adhesions. It’s a safe and uniquely powerful approach to pain and scar management.

The Dolphin Neurostim™ is engineered to detect and stimulate therapeutically active points with great scientific precision. This unique approach for the relief of pain and scar tissue and adhesions has been developed with input from healthcare professionals and has been thoroughly tested for over 30 years.
The end result is a simple, natural, and effective approach for the relief of pain and treatment of external and internal scarring. It is our belief the Dolphin Neurostim™ will greatly assist many suffering patients, dramatically improving their quality of life.

Sign up for interesting and useful information on hormonal health.